Yes, ibuprofen can lower PSA levels. Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen has been shown to reduce serum PSA by approximately 10 percent compared to men who don’t take these medications. That may sound like a small shift, but for men undergoing prostate cancer screening, it’s enough to potentially push a borderline result below the threshold that would trigger further testing.
How Ibuprofen Lowers PSA
PSA, or prostate-specific antigen, is a protein produced by prostate cells. When the prostate is inflamed, more PSA leaks into the bloodstream. Ibuprofen works by blocking enzymes called COX-1 and COX-2, which are key drivers of inflammation throughout the body, including in prostate tissue. When these enzymes are active, they convert fatty acids into prostaglandins, molecules that promote swelling, increased blood flow, and cell proliferation in the prostate.
By suppressing prostaglandin production, ibuprofen reduces the inflammatory environment around prostate cells. Less inflammation means less disruption of the normal barrier between prostate tissue and the bloodstream, so less PSA escapes into circulation. Importantly, this effect reduces the PSA reading without necessarily shrinking the prostate itself. The gland can remain the same size while producing a lower PSA number on a blood test.
Aspirin vs. Other NSAIDs
Not all NSAIDs affect PSA equally. Aspirin appears to have a substantially larger effect than ibuprofen and similar drugs. In one study of men with elevated PSA, aspirin users had PSA values roughly 32 percent lower than non-users across the full study population. Among men who had never smoked, the gap was even wider: aspirin users had PSA levels 49 percent lower than non-users. Non-aspirin NSAIDs like ibuprofen showed a more modest reduction of about 5 percent in the overall population, though the effect was larger in certain subgroups, reaching 23 to 28 percent depending on smoking history.
The difference likely comes down to how aspirin works. Unlike ibuprofen, which temporarily blocks COX enzymes, aspirin permanently disables them. Platelets and other cells need to produce entirely new COX enzymes before prostaglandin levels recover. This longer-lasting suppression may explain why aspirin has a more pronounced effect on PSA.
Why This Matters for Screening
The concern here is straightforward: if ibuprofen artificially lowers your PSA, a screening test might come back looking normal when it otherwise wouldn’t. The American Cancer Society has flagged this issue, noting that regular NSAID use may alter the detection of prostate cancer in men who take these medications. A PSA value that sits just below a biopsy threshold could delay further investigation.
This doesn’t mean ibuprofen causes missed cancers in every case. But for men whose PSA hovers near a decision point (typically around 4.0 ng/mL, though thresholds vary by age and clinical context), even a 10 percent reduction could be the difference between a follow-up recommendation and a clean bill of health. The risk is particularly relevant for men who take ibuprofen daily or several times a week for chronic pain, arthritis, or other conditions, rather than those who use it occasionally for a headache.
What to Do Before a PSA Test
If you’re scheduled for a PSA blood draw, make sure your doctor knows about any NSAIDs you take regularly, including ibuprofen, aspirin, and naproxen. There are no universal clinical guidelines specifying exactly how many days to stop ibuprofen before testing, but disclosing your usage allows your doctor to interpret the result with that context in mind. A doctor who knows you take daily ibuprofen may set a lower threshold for recommending follow-up, or may ask you to stop the medication for a period before retesting.
Ibuprofen’s effects on COX enzymes are reversible, typically wearing off within 24 hours of your last dose. Aspirin’s effects last longer because of its permanent COX blockade, with full enzyme recovery taking about 7 to 10 days. If your doctor does ask you to pause your NSAID before a PSA test, the timeline will depend on which drug you’re taking.
Does Lowering PSA Reduce Cancer Risk?
This is a separate and more complicated question. Some research suggests that NSAIDs may reduce the actual risk of developing prostate cancer, not just mask it on a blood test. The anti-inflammatory and anti-proliferative effects of COX inhibition could slow processes that contribute to tumor development. One large analysis found that NSAID users had an 18 percent lower odds of prostate cancer compared to non-users.
However, it’s not clear how much of that association reflects a true biological protection versus a screening artifact. If NSAIDs lower PSA, fewer men on these drugs get biopsied, and fewer cancers get detected, which could make the drugs appear protective even if they aren’t. The relationship between chronic inflammation, NSAID use, and prostate cancer development is still being untangled. Taking ibuprofen specifically to lower your cancer risk is not supported by current evidence.